[Gene therapy for peripheral arterial diseases in diabetes mellitus].
Makino
Hirofumi
H
Department of Geriatric Medicine, Osaka University Medical School.
Ogihara
Toshio
T
Morishita
Ryuichi
R
D000818:Animals; D001157:Arterial Occlusive Diseases / Q000209:etiology / Q000628:therapy*; D002908:Chronic Disease; D048909:Diabetes Complications; D016228:Endothelial Growth Factors / Q000008:administration & dosage / Q000235:genetics; D016222:Fibroblast Growth Factor 2 / Q000008:administration & dosage / Q000235:genetics; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D017228:Hepatocyte Growth Factor / Q000008:administration & dosage / Q000235:genetics; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000008:administration & dosage / Q000235:genetics; D008222:Lymphokines / Q000008:administration & dosage / Q000235:genetics; D017202:Myocardial Ischemia / Q000209:etiology / Q000628:therapy*; D018919:Neovascularization, Physiologic / Q000235:genetics; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016222:Fibroblast Growth Factor 2; D017228:Hepatocyte Growth Factor